Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yingying Liao

Showing results (31-40 of 49) with videos related to

Pageof 5
Sort By:
Scientific Reports|August 8, 2025
Phylogenetic and functional analysis of MYB genes unraveling its role involved in anthocyanin biosynthesis in H macrophyllaYingying Liao, Wenwen Zhao, Yu Wang, et al.
Clinical and Experimental Dermatology|June 11, 2025
Dose modulation strategies in psoriatic patients: real-world comparison between secukinumab and brodalumab for up to one year after dose spacingLuca Mastorino, Paolo Dapavo, Michela Ortoncelli, et al.
Frontiers in Immunology|May 4, 2026
Correction: The FGF-FGFR axis as an immune-metabolic rheostat in gastrointestinal inflammation and cancerKhamis Salem Saeed Saad, Chunfang Zhou, Guangxin Lu, et al.
Antibodies (Basel, Switzerland)|September 22, 2025
Monoclonal Antibodies and Small-Molecule Therapies for Lichen Planus: Targeted Immunomodulation and Emerging EvidenceFrancois Rosset, Nadia Sciamarrelli, Luca Mastorino, et al.
Biomedicines|May 27, 2026
Humanin and MOTS-c Attenuate Atrial Fibrillation by Suppressing Fibrosis and Mitochondrial DysfunctionYingying Liao, Jie Xu, Yuheng Jiao, et al.
Frontiers in Immunology|April 13, 2026
The FGF-FGFR axis as an immune-metabolic rheostat in gastrointestinal inflammation and cancerKhamis Salem Saeed Saad, Chunfang Zhou, Guangxin Lu, et al.
Clinical and Experimental Dermatology|January 8, 2025
Drug survival, effectiveness, and safety of guselkumab for moderate-to-severe psoriasis for up to 4 yearsLuca Mastorino, Paolo Dapavo, Michela Ortoncelli, et al.
Cell Death and Differentiation|May 23, 2024
MLKL promotes hepatocarcinogenesis through inhibition of AMPK-mediated autophagyXianjun Yu, Mengyuan Feng, Jian Guo, et al.
New Microbes and New Infections|September 16, 2024
Automated data collection tool for real-world cohort studies of chronic hepatitis B: Leveraging OCR and NLP technologies for improved efficiencyXiaomei Zhou, Tao Zeng, Yibo Zhang, et al.
Frontiers in Oncology|August 21, 2023
Pan-cancer analysis reveals that G6PD is a prognostic biomarker and therapeutic target for a variety of cancersTao Zeng, Bin Li, Xin Shu, et al.
Pageof 5

Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
Scientific Reports|August 8, 2025
Phylogenetic and functional analysis of MYB genes unraveling its role involved in anthocyanin biosynthesis in H macrophyllaYingying Liao, Wenwen Zhao, Yu Wang, et al.
Clinical and Experimental Dermatology|June 11, 2025
Dose modulation strategies in psoriatic patients: real-world comparison between secukinumab and brodalumab for up to one year after dose spacingLuca Mastorino, Paolo Dapavo, Michela Ortoncelli, et al.
Frontiers in Immunology|May 4, 2026
Correction: The FGF-FGFR axis as an immune-metabolic rheostat in gastrointestinal inflammation and cancerKhamis Salem Saeed Saad, Chunfang Zhou, Guangxin Lu, et al.
Antibodies (Basel, Switzerland)|September 22, 2025
Monoclonal Antibodies and Small-Molecule Therapies for Lichen Planus: Targeted Immunomodulation and Emerging EvidenceFrancois Rosset, Nadia Sciamarrelli, Luca Mastorino, et al.
Biomedicines|May 27, 2026
Humanin and MOTS-c Attenuate Atrial Fibrillation by Suppressing Fibrosis and Mitochondrial DysfunctionYingying Liao, Jie Xu, Yuheng Jiao, et al.
Frontiers in Immunology|April 13, 2026
The FGF-FGFR axis as an immune-metabolic rheostat in gastrointestinal inflammation and cancerKhamis Salem Saeed Saad, Chunfang Zhou, Guangxin Lu, et al.
Clinical and Experimental Dermatology|January 8, 2025
Drug survival, effectiveness, and safety of guselkumab for moderate-to-severe psoriasis for up to 4 yearsLuca Mastorino, Paolo Dapavo, Michela Ortoncelli, et al.
Cell Death and Differentiation|May 23, 2024
MLKL promotes hepatocarcinogenesis through inhibition of AMPK-mediated autophagyXianjun Yu, Mengyuan Feng, Jian Guo, et al.
New Microbes and New Infections|September 16, 2024
Automated data collection tool for real-world cohort studies of chronic hepatitis B: Leveraging OCR and NLP technologies for improved efficiencyXiaomei Zhou, Tao Zeng, Yibo Zhang, et al.
Frontiers in Oncology|August 21, 2023
Pan-cancer analysis reveals that G6PD is a prognostic biomarker and therapeutic target for a variety of cancersTao Zeng, Bin Li, Xin Shu, et al.
Pageof 5